ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China flag China · Delayed Price · Currency is CNY
11.37
+0.29 (2.62%)
At close: Jul 24, 2025, 2:57 PM CST

ChemPartner PharmaTech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2016 - 2020
5,7273,1853,8095,1846,8827,362
Upgrade
Market Cap Growth
10.11%-16.38%-26.51%-24.68%-6.52%11.09%
Upgrade
Enterprise Value
5,9003,3704,1855,5748,3907,812
Upgrade
Last Close Price
11.506.427.6510.4113.8114.67
Upgrade
PE Ratio
---13.69-47.63
Upgrade
Forward PE
-50.4050.4050.4050.4050.40
Upgrade
PS Ratio
5.743.283.353.914.074.97
Upgrade
PB Ratio
4.602.572.612.173.463.00
Upgrade
P/TBV Ratio
4.812.693.013.5811.3110.70
Upgrade
P/FCF Ratio
52.5732.19--74.63-
Upgrade
P/OCF Ratio
37.4218.9425.2319.7518.2021.45
Upgrade
EV/Sales Ratio
5.923.473.684.204.965.27
Upgrade
EV/EBITDA Ratio
110.10--380.0347.4125.60
Upgrade
EV/EBIT Ratio
----128.4738.75
Upgrade
EV/FCF Ratio
54.1634.06--90.98-
Upgrade
Debt / Equity Ratio
0.400.420.440.410.880.47
Upgrade
Debt / EBITDA Ratio
9.3615.638.589.946.733.74
Upgrade
Debt / FCF Ratio
4.605.19--18.94-
Upgrade
Asset Turnover
0.460.440.360.330.410.38
Upgrade
Inventory Turnover
44.4139.0724.3117.9118.7414.98
Upgrade
Quick Ratio
1.761.671.481.640.561.00
Upgrade
Current Ratio
1.941.861.701.750.691.17
Upgrade
Return on Equity (ROE)
-14.37%-16.79%-47.67%17.30%-18.11%6.48%
Upgrade
Return on Assets (ROA)
-2.16%-2.74%-1.31%-1.49%0.98%3.19%
Upgrade
Return on Capital (ROIC)
-2.46%-3.16%-1.50%-1.69%1.11%3.73%
Upgrade
Return on Capital Employed (ROCE)
----2.00%6.00%
Upgrade
Earnings Yield
-3.39%-7.11%-24.07%7.30%-5.85%2.10%
Upgrade
FCF Yield
1.90%3.11%-1.32%-1.42%1.34%-0.69%
Upgrade
Dividend Yield
-----0.48%
Upgrade
Payout Ratio
---9.88%-36.94%
Upgrade
Buyback Yield / Dilution
-8.16%-1.01%-0.02%-0.31%0.64%-
Upgrade
Total Shareholder Return
-8.16%-1.01%-0.02%-0.31%0.64%0.48%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.